Enterocolitis, Pseudomembranous clinical trials

The registry lists 29 studies for Enterocolitis, Pseudomembranous across more than 10 countries. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-23.

Studies

Recruiting first, then most recently updated. Showing 29 of 29 — search for more.

• Vancomycin Taper to Prevent Recurrent Clostridioides DifficileRecruitingNCT07328971Phase 31 country
• Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
• Stool Transplants to Treat Refractory Clostridium Difficile ColitisRecruitingNCT02127398Phase 21 country
• Safety and Efficacy of Fecal Microbiota TransplantationRecruitingNCT04014413Not applicable1 country
• Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.TerminatedNCT03756454Phase 41 country
• REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTsActive, not recruitingNCT056227211 country
• A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionCompletedNCT05831189Phase 31 country
• Effect of Antibiotics on Enteric Neurons and GliaCompletedNCT05834036Phase 41 country
• Bezlotoxumab Versus FMT for Multiple Recurrent CDIWithdrawnNCT05077085Phase 41 country
• Antimicrobial Stewardship Program for Clostridium Difficile Infection.CompletedNCT029514811 country
• Loop Ileostomy With Colonic Lavage for Fulminant Clostridium Difficile ColitisTerminatedNCT02347280Not applicable1 country
• Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD TreatmentCompletedNCT00182429Phase 31 country
• Fecal Microbiota Transplantation for Severe Clostridium Difficile InfectionCompletedNCT03427229Phase 2
• Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile InfectionCompletedNCT00304356Phase 31 country
• Addition of Lactobacillus to Metronidazole in Treatment of CDADWithdrawnNCT00304863Phase 41 country
• Small Bowel Transit Time in Clostridium Difficile ColitisTerminatedNCT013097501 country
• Extended Treatment With Vancomycin for Clostridium Difficile ColitisWithdrawnNCT00861887Not applicable1 country
• Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile ColitisCompletedNCT003048891 country
• Optimal Surgical Treatment Of Fulminant Clostridium Difficile ColitisTerminatedNCT01441271Not applicable1 country
• A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaTerminatedNCT00466635Phase 31 country
• A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaCompletedNCT00382304Phase 21 country
• A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCompletedNCT00106509Phase 33 countries
• A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated DiarrheaCompletedNCT00034294Phase 24 countries
• A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaCompletedNCT00196794Phase 314 countries
• Response of Clostridium Difficile Infection to Metronidazole TherapyCompletedNCT003043691 country
• Fecal Bacterial Flora in Clostridium Difficile-Associated DiarrheaCompletedNCT003048761 country
• Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin AntibodyCompletedNCT003044081 country
• Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated DiarrheaCompletedNCT010583561 country
• The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot StudyTerminatedNCT00164099Phase 41 country